Basel Medical Group Ltd (BMGL)
| Market Cap | 13.59M -82.7% |
| Revenue (ttm) | 8.92M +13.0% |
| Net Income | -8.35M |
| EPS | -0.44 |
| Shares Out | 18.79M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 18,375 |
| Open | 0.7600 |
| Previous Close | 0.7635 |
| Day's Range | 0.7200 - 0.7748 |
| 52-Week Range | 0.4872 - 9.4000 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 26, 2026 |
About BMGL
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman’s health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatm... [Read more]
News
Basel Medical resolves Nasdaq filing deficiency
Basel Medical (BMGL) received notification from Nasdaq that based on the company’s amended annual report on Form 20-F for FY25, filed with the SEC on March 13, Nasdaq has now…
Compliance With Nasdaq Periodic Filing Requirement
Singapore, March 24, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that based on the Company's amended a...
Basel Medical receives noncompliance notification from Nasdaq
Basel Medical (BMGL) announced that it has received notification from Nasdaq that based on the closing bid price of the company’s shares for the last 30 consecutive business days, the…
Receipt of Delinquency Notification from Nasdaq
Singapore, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that it has received notification from Nasdaq that based on the closing bid price o...
Basel Medical receives noncompliance notification from Nasdaq
Basel Medical (BMGL) announced that it has received notification from Nasdaq that the company’s annual report on Form 20-F for the fiscal year ended June 30 was incomplete and that…
Basel Medical says putting on hold acquisition of BTC digital asset
Basel Medical (BMGL) announced that it is putting on hold on the acquisition of BTC digital asset. After thorough discussions, Basel and the consortium of Bitcoin ($BTC) holders have mutually…
Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset
Singapore, July 17, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it is putting on hold on the acquisition of BTC digital asset. After thorough...
Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising
Singapore, June 26, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that Cathay Securities, Inc., as the representative of the several underwriters of ...
Basel Medical Group Ltd trading resumes
11:07 EDT Basel Medical (BMGL) Group Ltd trading resumes
Basel Medical Group Ltd trading halted, volatility trading pause
11:02 EDT Basel Medical (BMGL) Group Ltd trading halted, volatility trading pause
Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility
Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today reaffirmed the strength of its underlying financial performance and strategic outlook, despit...
Basel Medical enters $1B bitcoin purchase agreement
Basel Medical (BMGL) Group has entered into a purchase agreement with a consortium of Bitcoin holders for the purchase by the Company of up to 10,000 BTC by issuing of…
Basel Medical Group Ltd Enters into US$ 1.0 Billion Bitcoin (BTC) Purchase Agreement
Singapore, May 22, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it has entered into a purchase agreement with a consortium of Bitcoin (BTC) ho...
Basel Medical subsidiary awarded S$375M contract
Basel Medical (BMGL) Group announced that its subsidiary has been awarded a significant contract worth S$375M by Pancare Technology International to supply essential healthcare products in Asia-Pacifi...
Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities
Singapore, May 20, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that its subsidiary has been awarded a significant contract worth S$375 million by ...
Basel Medical begins negotiations for $1B bitcoin acquisition
Basel Medical (BMGL) Group has begun exclusive negotiations for a $1N BTC acquisition that will diversify its treasury reserves to a very large extent, while maintaining its core focus on…
Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move
Singapore, May 16, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it has begun exclusive negotiations for a US$1 billion BTC acquisition that wi...
Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia
Singapore , April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcar...
Basel Medical to acquire Bethesda Medical, terms undisclosed
Basel Medical (BMGL) announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. to acquire Bethesda Medical, a Singapore-based healthcare provider specializing in diagn...
Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia
Singapore, April 11, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. Ltd. to acquire B...
Basel Medical Group Ltd Announces Exercise of Overallotment Option
Singapore, March 19, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the “Company”) (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, ...
Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering
Singapore, March 03, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the “Company”) (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, ...
Basel Medical opens at $4.19, IPO priced at $4 per share
Basel Medical (BMGL) filed for an initial public offering of 2.205M ordinary shares. Cathay Securities is acting as the underwriter for this offering. Basel Medical Group is a medical specialist…
Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering
Singapore, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (the “Company”) (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, s...